NEW YORK, June 27, 2017 /PRNewswire/ -- ExL Events has just announced the industry's first annual Life Science Investor Relations Forum, hosted on September 7–8, 2017 in Boston, MA. This inaugural event will bring together IR professionals to address the diverse set of challenges faced in the life science industry. ExL Events has assembled an expert speaking faculty who will provide two content-packed days of thought-provoking dialogue. This engaging and informative event will also offer ample networking time for IR professionals.
"We're excited about this conference, we've had professionals tell us they are hungry for an IR forum that focuses on the distinct challenges faced in the life science industry. We're happy to be able to provide educational content that will bring peers together to work through these challenges," said Megan Heburn, ExL Events Conference Director.
Hosted at the Revere Hotel in Boston, this event will stage some of the top names in Boston's booming biotech industry. Join speakers from Acorda Therapeutics, Agenus, Alnylam Pharmaceuticals, Auxocell, Bionevia, Bluebird Bio, Cheetah Medical, Roche, Sage Therapeutics, and many more!
This two-day, breakthrough event will be invaluable to all those interested in learning more about crisis communication tactics, the growing power of social media, how to deal with an activist shareholder, the role of IR in successful mergers and acquisitions and understanding the variety of interests of shareholders. This one-of-a-kind industry forum will explore detailed examinations of successfully marketing your company in a crowded marketplace, and how to position positive dialogues on investor attention in a constantly changing industry.
For more information and to register, visit http://bit.ly/2sBg9CS
- To share your expertise and join the speaking faculty, contact Megan Heburn at 212-400-6230 or firstname.lastname@example.org.
- For information on sponsorship and exhibition opportunities, contact Michael Somaiah at 917-242-3983 or email@example.com.
About ExL Events
ExL Events (aka "ExL Pharma") is a division of Questex, LLC and develops engaging, content-driven conferences and partnered events for dynamic industry audiences, including pharmaceutical, biotechnology, medical device, diagnostic and contract research organizations; hospital networks; physicians; and communications and other entities.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/just-announced-exl-events-presents-the-first-and-only-life-science-investor-relations-forum-join-us-september-78-2017-in-boston-for-this-unparalleled-event-300478987.html
SOURCE ExL Events